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Abstract: Shock is a clinical challenge to neonatal 
intensivists and pediatricians alike. It occurs in 
critically ill babies for many reasons, but the main 
cause is sepsis that kills more than a million newborn 
globally every year.
1 This article is designed to help 
young doctors and trainees have a better understanding 
of shock in the neonatal period and its management. 
The paper reviews the basic pathophysiology, risk 
factors, clinical investigation, management, supportive 
care, and complications in the common types of shock 
seen in neonates. Treatment is governed largely by the 
underlying cause, with the ultimate goal of achieving 
adequate tissue perfusion with delivery of oxygen and 
substrates to the cells, and removal of toxic metabolic 
waste products. Intervention needs to be anticipatory 
and urgent to prevent progression to uncompensated and 
irreversible shock respectively. Early recognition and 
urgent effective management are crucial to successful 
outcomes.
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The attack rate for neonatal sepsis is variable 
(from <1% to >35% of live births) based on gestational 
age and time of onset (early<72 hours after birth) or 
late (>72 hours after birth).
2 Neonates with sepsis may 
present with or progress to septic shock, exemplified 
initially by cardiovascular dysfunction requiring fluid 
resuscitation or inotropic support.
3 If the progression 
of infection cannot be stopped, end organ damage 
and death will ensue. While the true incidence is 
not known, a recent retrospective cohort study of 
3800 neonates admitted to the NICU over a 6 year 
period reported septic shock in 1.3% with an associated 
mortality peaking at 71% for extremely low birth weight 
(ELBW) neonates <1000g
7. There are few published 
data regarding the pathophysiology of septic shock in 
neonates.
Shock is a complex clinical syndrome characterized 
by acute failure of the circulatory system to maintain 
adequate tissue and organ perfusion. This leads to 
inadequate oxygen and nutrient substrate delivery to 
body tissues and compromised metabolic waste product 
removal. This results in cellular dysfunction that may 
eventually lead to cell death, organ failure and death of 
the entire organism itself.
Adequate tissue perfusion requires a combination of 
three major factors: (1) cardiac output; (2) integrity 
and maintenance of vasomotor tone of local arterial, 
venous, and capillary vascular beds, and (3) the ability 
of the blood to deliver oxygen and metabolic substrates, 
and remove metabolic wastes. 
Cardiac output is the product of heart rate and 
stroke volume. In the neonate, cardiac output is 
more dependent on heart rate than stroke volume. 
Very rapid heart rates >180 beats per minute (bpm) and 
slow heart rates of <80 bpm are likely to compromise 
cardiac output if prolonged. However, not all infants 
with subnormal heart rates have impaired perfusion. 
At high rates, ventricular filling time and end-diastolic 
volume become compromised and myocardial oxygen 
consumption is increased. Because myocardial perfusion 
occurs during diastole, further acceleration in the heart 
rate may cause undesirable cardiac ischemia, leading to 
ventricular dysfunction.
4 The other major determinant 
of cardiac output is stroke volume that is influenced by 
preload, afterload, and myocardial contractility.
Preload – correlates to the myocardial end-diastolic 
fiber length that is determined by the volume of blood 
filling the ventricles during diastole. Increase in preload 
increases stroke volume up to a peak value, beyond 
which stroke volume falls in accordance to Starling’s 
law.
Afterload – is the force generated by the myocardium 
during ejection against systemic and pulmonary vascular 
resistance. Reduction in afterload will increase stroke 
volume, provided other variables remain constant. 18
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Contractility – is a semi-quantitative method 
of measuring ventricular function. An increase in 
contractility will increase the stroke volume provided 
preload and afterload remain unchanged. The main 
determinant is the percentage fractional shortening, 
which depends on the ventricular end-diastolic and 
end-systolic diameter. 
Clinically significant alterations in preload, afterload 
and contractility may be achieved by vasoactive 
pharmacologic agents, inotropic agents, changes in 
blood volume, or a combination of these methods. 
Blood flow to tissues and organs is determined by their 
vascular beds that are under central and local auto vaso-
regulation control. This enables the different organs to 
maintain internal blood flow despite wide arterial blood 
pressure fluctuations. When auto-regulation is lost, 
blood flow becomes pressure passive, with ischemic or 
hemorrhagic consequences. The biochemical mediators 
of vasomotor tone are different for each vascular bed, 
and their complex interactions are not well understood. 
The ability of the blood to deliver oxygen and 
nutrients and remove metabolic excretory products 
relies mainly on adequate lung ventilation, oxygen-
carrying capacity, tissue perfusion and oxygen extraction 
by the cells. Although each gram of hemoglobin binds 
1.36mL of oxygen, fetal hemoglobin (HbF) binds 
oxygen more tightly than adult hemoglobin, but has 
a relatively reduced oxygen-unloading capacity at 
the tissue level. This leads to a shift of the oxygen-
hemoglobin dissociation curve to the left. Other factors 
that promote this shift are hypothermia and hypocarbia. 
Under these conditions, oxygen extraction by tissues 
may be decreased despite adequate delivery of oxygen. 
The mean blood pressure, rather than systolic pressure 
is used to determine the normal blood pressure from an 
indwelling arterial line as it is more likely to be free of 
artifacts such as resonance, thrombi, and air bubbles. 
The lower limits of the mean blood pressure during 
the first day of life are numerically the same as the 
gestational age of the infant. Most prematures achieve 
a mean blood pressure of 30 mm Hg or greater by the 
third day of life. The presence of fetal shunts such as 
patent ductus arteriosus (PDA) and patent foramen 
ovale (PFO) further influence the systemic and 
pulmonary blood flow in premature babies. Large shunts 
can cause volume overloading of the left heart (PDA) 
and lead to cardiac failure and other complications like 
hypotension. Shock unresponsive to inotropes in the 
first few days of life in preterm babies can be caused by 
a large PDA. Estimations of blood pressure (mean and 
systolic) have poor correlation with cardiac output in 
babies with a PDA.
3 
Oxygen delivery to the tissue is influenced by cardiac 
output and blood flow more than blood pressure. Systolic, 
diastolic and mean arterial blood pressure readings that 
are usually considered abnormal may not necessarily be 
pathological. Likewise, hypotension is not synonymous 
with shock but is a feature that is emergent in the later 
stages of shock. 19
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Determinants of cardiac function and oxygen delivery 
to tissues are shown in the algorithm (Figure 1) below:
Figure1: Determinants of cardiac function and oxygen 
delivery to tissues. Adapted from Strange GR. APLS: 
The Pediatric Emergency Medicine Course. 3
rd ed. Elk 
Grove Village, Ill: American Academy of Pediatrics; 
1998:34.
1. Types of shock
The main types of neonatal shock and their causes are:
•	 Hypovolemic	shock	caused	by	acute	blood	or	fluid	
and electrolyte loss.
•	 Cardiogenic	 shock	 caused	 by	 cardiomyopathy,	
myocardial ischemia, arrhythmias, and heart 
failure.
•	 Distributive	shock	caused	by	sepsis,	vasodilation,	
myocardial depression, or endothelial injury.
•	 Obstructive	shock	from	tension	pneumothorax	or	
cardiac tamponade
•	 Dissociative	 shock	 from	 severe	 anemia	 or	
methemoglobinemia
Hypovolemic shock
Hypovolemic shock is usually due to:
i.  antenatal haemorrhage (spotting during the 
third trimester, placenta previa, abruptio 
placenta, foeto-maternal transfusion, twin-to-
twin transfusion, birth injuries, birth asphyxia 
or rupture of umbilical vessels, spleen or liver)
ii.  post-natal blood loss - iatrogenic, or secondary 
to disseminated intravascular coagulation or 
vitamin K deficiency, or
iii. fluid and electrolyte loss in newborn secondary 
to gastrointestinal abnormalities, vomiting, 
diarrhea or heat stress . 
The clinical signs of shock vary with the severity of 
intravascular volume depletion that ranges from 25% 
in compensated shock, to 25-40% in uncompensated 
shock, and 40% or more in irreversible shock. The 
normal blood volume in different age groups is shown 
in Table 1.
Table 1: Normal Blood Volume in Different Age Groups
Age Group Blood Volume in 
ml/kg body weight
Preterm Infant 90 to 105
Newborn 83.3
6 months 86
I year 80
6 years 80
(Geigy Scientific Tables, 7
th Ed; 1971)
Although the circulating blood volume is relatively 
larger in neonates than adults, even small volume blood 
loss may result in shock in the neonate. The clinical 
features of hypovolemic shock are lethargy, mottling of 
the skin, cool peripheries, prolonged capillary refill – best 
tested by pressing on the skin of the chest, tachycardia, 
weak pulse, hypotension, and decreased urine output.
Oxygen Delivery to Tissues
Cardiac Output
Rate / 
Rhythm stroke volume
Preload Afterload 
Contractility
Hemoglobin level, 
Blood O2 saturation
Airway Breathing FIO220
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Cardiogenic shock
Cardiogenic shock in the neonate may be caused by:
1. Severe intra-partum asphyxia that is defined 
as metabolic acidemia at birth with pH < 7.00 
and base deficit > /= 12 mmol/l. Neonatal 
complications of intrapartum asphyxia include 
multi-organ failure and neonatal encephalopathy. 
While the most severe consequences are death and 
neurological or sensorial impairment, moderate to 
severe neonatal encephalopathy is associated with 
a high risk of cerebral palsy (especially quadriplegic 
or dyskinetic type) and/or cognitive disorders. 
Prognosis of neonatal encephalopathy can be 
accurately assessed by MR imaging.
 2. Primary structural heart disease like:
•	 Hypoplastic	 left	 ventricle,	 tricuspid	 atresia,	
pulmonary atresia or arrhythmias
•	 Myocardial	 ischemia	 that	 reduces	 myocardial	
contractility leading to papillary muscle 
dysfunction and secondary tricuspid valve 
insufficiency
•	 Myocardial	 dysfunction	 from	 cardiomyopathy	
or cardiac arrhythmias
•	 Shock	of	any	cause
•	 Mechanical	 reduction	 of	 cardiac	 function	
or venous return secondary to tension 
pneumothorax, diaphragmatic hernia or cardiac 
tamponade
3. Disturbance of transitional circulation due to 
persistent pulmonary hypertension in newborn, or 
patent ductus arteriosus in premature infants.
The four main clinical features of cardiogenic shock are 
tachycardia, tachypnea, hepatomegaly, and cardiomegaly. 
Other features are a heart murmur suggestive of tricuspid 
regurgitation, narrow pulse pressure, basal crackles, and 
decreased urine output. Peripheral edema and raised JVP 
are relatively uncommon in the neonate. 
Septic shock
The commonest form of distributive shock is septic 
shock that is the major cause of mortality and morbidity 
in neonates. Although the cardiac output may be normal 
or even increased, it may still be far too inadequate to 
deliver sufficient oxygen and substrate to the tissues 
because of mal-distribution of blood flow in the 
microcirculation, leading to decreased tissue perfusion. 
In septic shock, cardiac function may be depressed in 
the left ventricle more than the right.
6
The early phase of compensated septic shock is 
associated with increased cardiac output, decreased 
systemic vascular resistance, warm extremities, and 
wide pulse pressure. If effective therapy is delayed, 
cardiovascular performance deteriorates and cardiac 
output falls. It is to be noted that shock can ensue 
even with normal or increased cardiac output. Once 
the normal relationship between cardiac output and 
systemic vascular resistance breaks down, hypotension 
results from decreased vascular resistance. 
Neonates with sepsis have limited cardiac reserve 
and often present with hypotension and cardiovascular 
collapse. Urgent clinical diagnosis and treatment are 
mandatory for good clinical outcomes. The critically ill 
infant represents a diagnostic and therapeutic challenge 
that needs to be anticipated and met immediately.
The common organisms that cause neonatal septic 
shock are shown in Table 2.
Table 2: Common organisms causing neonatal septic 
shock
Gram-negative organisms Gram- positive organisms
•	 E.	coli •	 Group	B	Streptococcus
•	 Klebsiella •	 Staphylococcus
•	 Enterobacter •	 Listeria
•	 Pseudomonas •	 Enterococcus
•	 Proteus •	 Group	A	Streptococcus21
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2. Progression of shock/stages of shock
The clinical features of neonatal shock include weak 
cry, poor response to stimulation, lethargy, pallor or 
cyanosis, shallow respiration, cool extremities, sclerema 
neonatorum with hardening of skin over the extremities, 
poor capillary refill, hypothermia (core temperature), 
and hypotension. Infants with septic shock may 
have necrotic lesions around the mouth and mucus 
membranes of the mouth and nostrils, and bleeding 
into skin and other areas with onset of disseminated 
intravascular coagulation.
Table 3 : Comparison of the main cardiovascular features 
of 3 more common types of shock in the neonate 
CVS 
Features
Hypovolemic Cardiogenic
Early 
septic 
(warm)
Late 
septic 
(cold)
Arterial BP Low Low Low Low
Central 
venous 
pressure
Low Low Normal High
Pulse 
pressure Decreased Decreased Normal Decreased
Total 
peripheral 
resistance
High High Low High
Cardiac 
output Low Low Normal/
High Low
Core & 
peripheral 
skin 
temperature 
difference
Increased Increased Normal /
Decreased Increased
Adapted from Shock in the newborn. G.S. Levin
7 
www.ttuhsc.edu/.../documents/lectures/shockinthenew 
born.ppt - accessed 6 November 2012.
It is seen from the Table 3 that the cardiovascular 
features are similar between late septic shock and 
cardiogenic shock. The features differ little between 
hypovolemic and cardiogenic shock except for high 
CVP in cardiogenic shock and low CVP in hypovolemic 
shock. In early septic (warm) shock, the cardiovascular 
features appear normal except for low CVP, low total 
peripheral resistance, high or normal cardiac output and 
normal or increased core to skin temperature. 
Shock, if not managed competently, progresses 
through 3 phases: compensated, uncompensated, and 
irreversible, each with its own characteristic clinico-
pathological features and outcome. Distinguishing 
between them may be impossible. 
More important is the need to initiate prompt, 
aggressive treatment as soon as shock is anticipated or 
suspected. 
Compensated shock
In compensated shock, perfusion of the vital organs 
– the brain, heart, kidneys, adrenals, and liver are 
maintained. Alterations in vital signs, such as heart rate, 
respiratory rate, blood pressure, and temperature, are 
either absent or minimal. Angiotensin and vasopressin 
secretions are increased to enhance salt and water 
conservation by the kidneys. Myocardial contractility 
is increased by catecholamine release. Reduction in 
spontaneous activity decreases oxygen consumption by 
the body.
Uncompensated shock
Once the compensatory homeostatic mechanisms 
are exhausted, the clinical signs of pallor, tachycardia, 
cool peripheries, and prolonged capillary refill time will 
emerge as uncompensated shock ensues. Blood flow 
in the small blood vessels become sluggish, leading 
to platelet adhesion, activation of the coagulation 
cascade, bleeding and volume depletion. As the 
blood pressure falls, metabolic acidosis leads to rapid 
breathing, and oliguria or anuria as the kidneys start 
to fail with hypotension and poor organ perfusion. If 
urgent treatment is not forthcoming or is ineffective, 
progression to irreversible shock will ensue. As delivery 
of oxygen and nutrients becomes insufficient to meet 
tissue demands, anaerobic metabolism becomes the 22
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major source of energy production with excessive 
production of lactic acid that leads to metabolic acidosis, 
reduced myocardial contractility and impaired response 
to catecholamines. Chemical mediators, cytokines, 
histamines, xanthine oxidase, platelet aggregating 
factors and bacterial toxins are released in cases of septic 
shock causing reduction in tissue perfusion and oxidative 
phosphorylation. The sodium–potassium pump fails, 
the capillary endothelial integrity is disrupted and plasma 
proteins leak, with resultant loss of oncotic pressure and 
shift of intravascular fluids to the extravascular space. 
The algorithmn of decompensated shock is shown in 
Figure 2.
Figure 2: Algorithm of decompensated shock
 Initial Insult
Triggers Compensated Shock
Decompensated shock
Multisystem organ failure 
Irreversible shock 
Death
Irreversible shock
Early recognition of neonatal shock and appropriate 
intervention are vital to saving lives. Shock should be 
diagnosed and treated appropriately before hypotension 
occurs.
9 If reversible shock is not successfully treated, it 
will progress and cause multiple end-organ damage to 
the kidneys, liver, heart and brain that are sensitive to 
hypoxic-ischemic injury. It is not possible to identify the 
exact point of no return beyond which death is inevitable 
irrespective of the intensiveness of resuscitative 
measures and success in restoration of circulation. 
The diagnosis of irreversible shock is a retrospective 
one. Those who recover from uncompensated shock 
may have varying degrees of persistent multi-organ 
damage during and following recovery that needs to be 
identified and managed. These include acute tubular 
necrosis, and compromised myocardial contractility 
from prior inadequate myocardial perfusion. Liver and 
bowel compromise during shock may lead to GI bleeding 
from necrotizing enterocolitis especially in premature 
infants. 
Factors that suggest irreversibility of shock are:
•	 Ongoing	fluid/blood	requirement	despite	control	
of hemorrhage
•	 Persistent	 hypotension	 despite	 restoration	 of	
intravascular volume
•	 No	improvement	in	parameters	(cardiac	output/
blood pressure) despite inotropic support
•	 Futile	cycle	of	 uncorrectable	hypothermia,	hypo	
perfusion, acidosis, and coagulopathy
Laboratory tests 
Although a large array of laboratory tests is available, 
most lack specificity and practical utility. The suspected 
cause should guide what diagnostic tests are required. 
The tests should determine:
•	 Type	of	shock
•	 Cause	of	shock
•	 Severity	of	shock	-	whether	end	organ	damage	is	
present
•	 Presence	of	other	complications
•	 Type	of	management	and	prognosis
The following tests should be considered:
•	 Complete	 blood	 count	 to	 determine	 anaemia	
and blood loss; total and differential white blood 
cell counts for infection. Although both elevated 
WBC and low neutrophil counts can be predictive 
of neonatal sepsis, neutropenia is a better marker 
because of its greater specificity; few conditions 
other than sepsis and pre-eclampsia depress the 23
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neutrophil count of neonates
10. When defining 
neutropenia, one needs to bear in mind that 
neutrophil counts vary depending on gestational 
age, type of delivery, site of sampling and even 
altitude.
•	 Coagulation	 tests	 for	 DIC,	 liver	 failure	 and	
hypocoagulability states.
•	 Electrolytes,	 BUN/creatinine	 and	 urinalysis;	 and	
hepatic function tests to assess renal and liver 
function respectively.
•	 Chest	x-ray,	EKG,	cardiogenic	-	cardiac	enzymes	
and echocardiogram; obstructive - CT or V/Q 
scan (PE), echo (tamponade). An echocardiogram 
(heart ultrasound) or right heart (Swan-Ganz) 
catheterization may show low cardiac output 
(pumping action), confirming shock, and may also 
help to differentiate hypovolemic from cardiogenic 
shock 
•	 Serum	 lactate	 -	 to	 gauge	 the	 degree	 of 
hypoperfusion
•	 Pro-inflammatory	 cytokines	 such	 as	 IL-18	 a	
predictive marker that differentiates infected and 
non-infected neonates 
•	 Increase	in	the	chemokine	IP-10	is	a	sensitive	early	
marker of infection in neonates 
•	 More	 invasive	 testing	 is	 often	 required:	 arterial	
blood gas for O2/pH; central venous oxygen 
measurement, systemic vascular resistance, and 
cardiac output may be measured through special 
central venous catheters.
•	 Central	venous	oxygen	saturation	(ScvO2)	>70%
•	 Arterial	blood	gases	(especially	the	pH	and	base	
excess (BE))
•	 Mixed	venous	saturation
•	 If	septic	shock	is	suspected,	blood,	urine,	umbilical	
or wound cultures are advocated with head CT 
and lumbar puncture. Targeted imaging (US/CT) 
tests may help determine site and cause of volume 
depletion, and can include a CT scan or an X-ray 
of suspected areas.
•	 Endoscopy	may	be	performed	in	cases	of	bleeding	
in the gastrointestinal tract.
•	 Newer	 non-	 invasive	 tools	 such	 as	 functional	
echocardiography (FE) and near infrared 
spectroscopy (NIRS) may be used more regularly 
in future. FE provides a bedside means of measuring 
cardiac output, peripheral vascular resistance and 
organ blood flow in response to fluid and drug 
therapy. NIRS allows non- invasive monitoring of 
the end-organ perfusion.
Table 4: Tests recommended for septic shock
Tests specific for septic shock Expected results
blood culture positive
WBC  <4000 or >30,000 
(depends on age of neonate)
I/T Ratio  > 0.2
CRP  >2 mg/dl (EOS)
CRP  > 2 ng/ml
PCT  > 2 ng/ml
IL-8  > 70 pg/ml
PCR 16SrRNA??
sTREM-1   > 60 nanogram/ml
CD 64 and combination tests 
I/T ratio + CRP
 PCT + CRP
 IL-8 + CRP
•	 Urine Examination: Because of difficulties 
with collection of clean samples, and risks of 
catheterisation and supra-pubic aspiration, this 
investigation is often not done. The low rate of 
urinary tract infection in the new born has led to 
recommendations against routine urine culture to 
diagnose sepsis. Urine bacterial antigens are no 
substitutes as their accuracy and reliability is very 
poor and their routine use should be abandoned. 
•	 Cerebrospinal Fluid (CSF)
  There is controversy as to whether CSF examination 
should be a routine at each sepsis work-up. 24
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The 2012 AAP clinical report (www.pediatrics.
org/cgi/doi/10.1542/peds.2012.0541) recommends 
that LP be performed for an infant with any of the 
following clinical conditions:
•	 A	positive	blood	culture
•	 Clinical	findings	that	are	highly	suggestive	of	
sepsis 
•	 Laboratory	data	strongly	suggestive	of	sepsis
•	 Worsening	clinical	status	while	on	antibiotic	
therapy
Shock index
The shock index is easily calculated (heart rate 
divided by systolic blood pressure) and can provide clues 
to the severity of the patient’s condition. A normal 
index ranges from 0.5-0.7; repeated values >1.0 indicate 
decreased left ventricular function and are associated 
with higher mortality.
Management
Shock should be diagnosed and managed before 
onset of hypotension. Absence of hypotension does not 
preclude shock that is mainly related to blood flow rather 
than blood pressure; the mean blood pressure may be in 
the normal range due to compensatory mechanisms.
11-12 
In the evaluation of blood pressure, physiological 
variability with age and gestational age should be taken 
in account.
12 Thirty mmHg is the absolute minimum 
tolerable in extremely premature infants.
13 In critically 
ill prematures, refractory hypotension may be related to 
patent ductus arteriosus, intraventricular haemorrhage 
and poor prognosis,
14 while in healthy prematures, lower 
mean blood pressure levels may be accepted as being 
associated with appropriate cerebral perfusion and 
normal cardiac output. In septic shock hypotension is 
not permissive and needs therapeutical intervention. 
There are many well-defined algorhythmic management 
guidelines available with large practice variability in the 
treatment of neonatal septic shock. However, early and 
aggressive management of septic shock is vital right from 
the onset, because each hour of delay increases the risk 
of death 2-fold. 
The immediate aim of management is to optimize 
perfusion and delivery of oxygen and nutrients to the 
tissues. The American College of Critical Care Medicine 
estimates that 60 min is the average time needed to 
provide adequate circulatory support and block the 
development of shock.
15 The first step in managing 
shock in the newborn during the first 5 minutes is to 
recognize cyanosis, respiratory distress and decreased 
perfusion
7. This should be followed immediately by 
airway access and ventilation to optimise oxygenation. 
Rapid peripheral, central venous, or intraosseus access 
is of primary importance in the initial management 
of the newborn in shock. Any baby with shock and 
hepatomegaly, cyanosis or a pressure gap between upper 
and lower limbs should be treated with prostaglandin 
within 10 min of birth until congenital heart disease is 
excluded.
14-1525
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Table 5: Recommended management of neonatal shock
A.  Early detection Early recognition and intervention are crucial for favourable outcomes.
B.  Aggressive fluid therapy
Mortality is significantly reduced if hemodynamic function is optimized early.
16 There is no advantage in using 
crystalloids instead of colloids in septic shock.
17 Intraventricular haemorrhage and infection transmission is lower 
with crystalloids. The incidence of pulmonary edema is less with 5% albumin.
18 Bolus resuscitation as a life-saving 
intervention in shock without hypotension is challenged. Infants who do not diurese after adequate fluids may 
need diuretics to prevent fluid overload.
14
C. Antibiotics
Blood cultures, biochemical markers for sepsis, blood glucose and ionized calcium should be taken before 
initiating antibiotics for suspected sepsis.
19 Ampicillin plus gentamycin is more effective than cefotaxime plus 
gentamycin.
20 Cefotaxime is preferred for meningitis.
D.  Respiratory support
Respiratory failure accompanying shock requires elective ventilation. Anoxia and over-distension of alveoli- a 
potent IL-6 inducer should be avoided
E.  Metabolic support
There is no consensus on ideal blood sugar but it should not be lower than 30 mg/dL.
21 Level of 175 mg/dL or more 
has a 2.5X increased mortality; same in ELBW babies with level above 150 mg/dL. Insulin should be used only 
when sugar level exceeds 180mg/dL in refractory shock and unfavourable response newborn.
22
There is no evidence to support bicarbonate therapy in acidemia of septic shock. Hypocalcemia is a reversible 
cause of cardiac dysfunction; it should be normalized. Corticosteroids often used in septic shock when volume 
expansion and inotropes are unable to raise BP, appear to increase mortality in a subset of patients.
23 Consequently, 
corticosteroids are recommended for refractory shock when adrenal insufficiency is suspected.
24
F. Nutrition
In infants with poor muscle mass and energy reserves, metabolic requirements increase due to hypercatabolic 
state in sepsis. Appropriate enteral feeding to reduce bacterial translocation from gut mucosa and preserve gut 
mucosal function is advocated.
G.	 Cardiovascular	support
Inotropes like dopamine, dobutamine, epinephrine and norepinephrine are indicated via iv or io route before 
central access is achieved when myocardial contractility remains poor despite adequate volume replacement. 
Delay increases mortality 20-fold.
25
Epinephrine and norepinephrine raise mean arterial pressure but epinephrine causes adverse hyperglycemia 
requiring insulin, increased plasma lactate and inadequate gastric mucosa perfusion.
26
Dopamine is the first line drug although dobutamine raises systemic blood flow more effectively.
27 It reduces TSH 
release making hypothyroidism diagnosis difficult. The best vasoactive drug schedule for premature transition 
shock is low dose dopamine and dobutamine, Epinephrine is a potent inotrope and chronotrope, and a systemic 
and pulmonary vasodilator. Norepinephrine is indicated for “warm” shock in neonates.26
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H.  Adjunctive treatments
Nitric Oxide is used in PPH (persistent pulmonary hypertension).
28 
Triiodothyronine is an effective inotrope in newborns with thyroid insufficiency.
29
Phosphodiesterase inhibitors are used if cardiac output does not improve and high systemic vascular resistance 
persists.
Milrinone, an inodilator (inotrope/vasodilator), and selective phosphodiesterase type III inhibitor improves 
myocardial contractility and relaxation by effects on calcium.
2 In the vasculature it relaxes arterial and venous 
smooth muscle It is advocated in “cold shock” with high peripheral resistance. Limited data is available on use of 
milrinone in preterm infants.
Arginine-vasopressin (AVP)
30: Endogenous AVP, released in response to hypovolemia and hypotension, shows 
a biphasic response in septic shock, with initial high levels followed by inappropriately low levels in later stages. 
This justifies exogenous administration to correct hypotension in vasodilatory shock in children and also in 
extremely-low-birth weight infants.
Terlipressin (TP) is a synthetic AVP analogue with prolonged action; it has higher affinity for vascular receptors 
than vasopressin.
2 It is an effective rescue treatment for refractory vasodilatory septic shock.
31 It is advocated as a 
last resort when septic patients remain hypotensive despite fluid resuscitation and high doses of cathecholamine.
32
Levosimendan (LS) is an inodilator that has cardio-protective and anti-inflammatory effects
2. It is a calcium-
sensitizing agent that acts by binding to myocardial troponin C, allowing more efficient contraction. In peripheral 
vascular beds, LS causes vascular relaxation which reduces cardiac afterload and promotes coronary vasodilation. 
LS’s potential utility is due to a number of reasons; it can be used with conventional inotropic agents, it has a 
simple dosing regimen and does not worsen the diastolic dysfunction often present in structural heart disease. 
Clinical experience confirms the potential beneficial effects of LS infusion in restoring hemodynamics in infants 
with low cardiac output septic shock resistant to catechol-amines.
33
Granulocyte and granulocyte-macrophage colony stimulating factors (G-CSF, GM-CSF) increase the number 
of circulating white cells but do not reduce mortality from neonatal sepsis or septic shock.
34
Pentoxifylline is a carbonic anhydrase inhibitor that improves white cell function. One RCT in prematures shows 
significantly reduced multi-organ failure, mortality and coagulopathy with improved BP blood.
35
Intravenous immunoglobulin (IVIG):	Polyclonal	and	IgM-enriched	IVIG	reduces	mortality	from	sepsis	in	the	
newborn.	Tumour	necrosis	factor	can	be	blocked	by	various	antagonists.	Generally	immunomodulators	have	
shown frustrating results in newborn septic shock management.
36
Protein C. Low PC plasma activity correlates with adverse outcomes, such as multiple organ failure and 
mortality.
37,38 It is a useful predictor of organ failure in severe sepsis and an important factor of high diagnostic 
and negative prognostic significance.
39,40 It is successfully used in term neonates and preterms at high-risk of 
haemorrhage with sepsis-induced coagulopathy.
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